| 1 |
32164276 | Precision Medicine Management of Chronic Lymphocytic Leukemia. | 2020 Mar 10 |
1 |
| 2 |
32253666 | Evolution in the management of chronic lymphocytic leukemia in Japan: should MRD negativity be the goal? | 2020 May |
1 |
| 3 |
31208944 | Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trial. | 2019 Aug |
1 |
| 4 |
31364186 | Chronic lymphocytic leukemia: 2020 update on diagnosis, risk stratification and treatment. | 2019 Nov |
1 |
| 5 |
29164608 | The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab. | 2018 Jan |
1 |
| 6 |
29205267 | The absolute percent deviation of IGHV mutation rather than a 98% cut-off predicts survival of chronic lymphocytic leukaemia patients treated with fludarabine, cyclophosphamide and rituximab. | 2018 Jan |
1 |
| 7 |
30504317 | Selecting Frontline Therapy for CLL in 2018. | 2018 Nov 30 |
1 |
| 8 |
27678008 | Major prognostic value of complex karyotype in addition to TP53 and IGHV mutational status in first-line chronic lymphocytic leukemia. | 2017 Dec |
1 |
| 9 |
29025740 | FCR achieves long-term durable remissions in patients with IGHV-mutated CLL. | 2017 Nov 23 |
1 |
| 10 |
29222275 | The mutational landscape of chronic lymphocytic leukemia and its impact on prognosis and treatment. | 2017 Dec 8 |
1 |
| 11 |
26492934 | Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia. | 2016 Jan 21 |
1 |
| 12 |
19340428 | IGHV gene mutational status and LPL/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide. | 2009 Dec |
1 |
| 13 |
15801955 | p53 Aberrations do not predict individual response to fludarabine in patients with B-cell chronic lymphocytic leukaemia in advanced stages Rai III/IV. | 2005 Apr |
1 |